Sun Pharma and Philogen Team Up to Fight Cancer with New Drug Fibromun
Sun Pharmaceutical Industries Limited (Sun Pharma) and Philogen S.p.A (Philogen) have announced a global exclusive agreement to commercialize Fibromun (L19TNF), an anti-cancer immunotherapy product. Fibromun is currently being tested in trials for treating soft tissue sarcoma and glioblastoma, which are cancers with significant unmet medical needs.
Under this agreement, Sun Pharma will have exclusive global rights to commercialize Fibromun, while Philogen will continue conducting clinical trials, seek marketing authorization, and manufacture the product. The companies will share post-commercialization profits, with Sun Pharma receiving 55% and Philogen 45%.
Dilip Shanghvi, Chairman and Managing Director of Sun Pharma, expressed optimism about Fibromun’s potential, stating, “Fibromun’s progress through development has been quite encouraging and it has potential to be an important option for treatment of soft-tissue sarcomas and other cancers with significant unmet medical needs.”
Prof. Dr. Dario Neri, CEO and CSO of Philogen, added, “We are pleased to extend our collaboration with Sun Pharma. Our data has shown that Fibromun has promising therapeutic activity, especially in glioblastoma, inducing long-lasting anti-tumor responses in some patients.”
This is the second collaboration between Sun Pharma and Philogen, following their May 30, 2023 agreement to commercialize Nidlegy, a product aimed at treating locally advanced melanoma, in Europe, Australia, and New Zealand. The first Marketing Authorization Application for Nidlegy has already been submitted to the European Medicines Agency (EMA).
Doubts Revealed
Sun Pharma -: Sun Pharma is a big company in India that makes medicines to help people get better.
Philogen -: Philogen is a company from Italy that also makes special medicines to treat diseases like cancer.
Fibromun -: Fibromun is a new medicine that is being tested to help fight cancer.
immunotherapy -: Immunotherapy is a type of treatment that helps your body’s own defense system fight diseases like cancer.
soft tissue sarcoma -: Soft tissue sarcoma is a kind of cancer that starts in the soft parts of your body, like muscles or fat.
glioblastoma -: Glioblastoma is a very serious type of brain cancer.
clinical trials -: Clinical trials are special tests done with people to make sure new medicines are safe and work well.
regulatory approval -: Regulatory approval means getting permission from the government to sell a new medicine.
post-commercialization profits -: Post-commercialization profits are the money made after a new medicine is sold to people.
Nidlegy -: Nidlegy is another medicine that Sun Pharma and Philogen worked on together before.
